During the past decade, Dr Anil K Gupta Medicine Professional Corporation conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 13 clinical trials were completed, i.e. on average, 72.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 10 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dr Anil K Gupta Medicine Professional Corporation" #1 sponsor was "Pfizer" with 6 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dr Anil K Gupta Medicine Professional Corporation" #1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "TIMI Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Dr Anil K Gupta Medicine Professional Corporation" are "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Influenza" (2 trials), "Obesity" (2 trials) and "Respiratory Syncytial Virus" (2 trials). Many other conditions were trialed in "Dr Anil K Gupta Medicine Professional Corporation" in a lesser frequency.

Most popular intervention types in "Dr Anil K Gupta Medicine Professional Corporation" are "Drug" (20 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Dulaglutide" (2 trials), "Methotrexate" (2 trials), "Tirzepatide" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dr Anil K Gupta Medicine Professional Corporation" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Dr Anil K Gupta Medicine Professional Corporation". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Dr Anil K Gupta Medicine Professional Corporation, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Dr Anil K Gupta Medicine Professional Corporation, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".